Learn More
Medchemexpress LLC Nitroaspirin | 175033-36-0 | MFCD00952953 | 98.6% | 331.28 g/mol | C16H13NO7 | 100MG

Supplier: Medchemexpress LLC HY123823100MG
Nitroaspirin is a nitric oxide-releasing derivative of aspirin that irreversibly inhibits cyclooxygenase (COX) and exhibits antiplatelet and antithrombotic activity. It is intended for research use to study nitric oxide signaling, inflammation, and cardiovascular pharmacology.
- Nitric oxide donor and COX inhibitor.
- Antiplatelet and antithrombotic properties relevant for cardiovascular research.
- Molecular formula C16H13NO7; molecular weight 331.28 g/mol.
- Purity approximately 98.6% as reported by supplier.
- Available as powder and solution preparations in multiple pack sizes, including 100 mg.
- Storage: powder -20°C (3 years); in solvent -80°C (6 months).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.